Work

Does Gleason score (GS) predict efficacy of abiraterone acetate (AA) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)? An analysis of AA phase 3 trials.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.20

Authors: Karim Fizazi, Thomas W. Flaig, Carsten-Henning Ohlmann, Howard I. Scher, Johann Sebastian De Bono, Dana E. Rathkopf, Charles J. Ryan, Thian San Kheoh, Jinhui Li, Mary Beth Todd, Thomas W. Griffin, Arturo Molina, Michael Stöckle

Institutions: Université Paris-Sud, Institut Gustave Roussy, University of Colorado Cancer Center, University of Colorado Anschutz, Saarland University, Memorial Sloan Kettering Cancer Center, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, UCSF Helen Diller Family Comprehensive Cancer Center, Janssen Research & Development (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589537503

Cites:

Cited by: 7

Related to: 10